author-photo

Anna Sicuranza

University of Siena

50

Papers

218

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Pro-Inflammatory and Pro-Oxidative Changes during Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.

2021 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (1)
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma.

2021 American journal of blood research
Show All
- Source
- Cite
- Save
Citations (1)
The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose.

2021 Biomedicines
Show All
- Source
- Cite
- Save
Citations (0)
Minimal Residual Disease (MRD) at 10-6 Measured By Next Generation Flow (NGF) during Daratumumab Consolidation Therapy: Analysis at 18 Months Follow up of DART4MM Study (Daratumumab Treatment For Multiple Myeloma Eradication)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma.

2020 American journal of blood research
Show All
- Source
- Cite
- Save
Citations (3)
Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice

2020 Journal of Personalized Medicine
Show All
- Source
- Cite
- Save
Citations (2)
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant).

2020 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (4)
Low Cholesterol, Low-Density Lipoprotein (LDL) and Triglycerides Plasma Levels Are Associated with Lower Risk of Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Nilotinib

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (1)